Also inside: FDA clears the first drug for narcolepsy Type 1.

August 12, 2026

1. Lilly sues 6 companies over alleged retatrutide sales Full story

2. FDA approves Moderna’s mRNA flu vaccine Full story

3. Specialty pharmacy is becoming a lifeline for uninsured patients. How Cottage Health + Sinai Chicago are building it here.

 

4. Court sides with Lilly, Novo Nordisk in GLP-1 antitrust fight Full story

5. FDA approves 1st drug for narcolepsy type 1 Full story

6. Expanding access was the first step. Harris Health, Ballad and Renown on what comes next here.

 

7. FDA approves new cholesterol pill, cuts LDL by more than half Full story

8. Lilly widens GLP-1 lead over Novo despite Wegovy pill gains Full story

Becker’s Learning Opportunities

9. 30,000 geriatricians are needed by 2030. Only 7,400 practiced in 2022. See the workforce response here.

10. Nearly 80% of physicians say they’d join an employer-run float pool. See what’s driving the shift here.

11. Northwell’s CMIO & peers on why AI pilots stall on the data, not the model. Here.

12. Becker’s August webinar lineup: patient flow, pharmacy access and denials. See the sessions here.

 

 

Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.

 
 

 

Contact Us, Feedback, or Questions – Email ldyrda@beckershealthcare.com

Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

Privacy Policy     

 

View our profile on LinkedIn Follow us on Twitter Follow us on Facebook Check out our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker’s Hospital Review, A Becker’s Healthcare Publication